Does GHK-Cu peptide really work for melasma? We checked

What did @courtney_peebles actually say?

Courtney kept it short: "Three months on George Casey here and I'm pretty happy. Looking really good." She clarified she was wearing tinted moisturizer, cream blush, and mascara. That's the whole claim, a personal result update with minimal hype and a clear disclosure about makeup. Credit where it's due, that's a more honest format than most peptide content on TikTok.

She's referring to GHK-Cu, a copper tripeptide that occurs naturally in human plasma and has been researched for skin remodeling, wound healing, and collagen stimulation. The caption explicitly says she's "not making medical promises," which is an unusual level of restraint for this category. She's positioning this as a personal anecdote, not a clinical endorsement, and the video largely delivers on that promise.

Does the science back this up?

The research on GHK-Cu is genuinely interesting, though it's nowhere near settled. The most compelling evidence is from in vitro and animal studies, with human clinical data still thin. Pickart and Margolina (2018, Biomolecules) summarized GHK-Cu's role in stimulating collagen synthesis, activating wound healing genes, and reducing oxidative stress in skin tissue. That's a real foundation.

For melasma specifically, the picture gets murkier. GHK-Cu has antioxidant properties that could theoretically reduce melanin overproduction triggered by UV-induced oxidative stress. But there are no large randomized controlled trials directly testing GHK-Cu against melasma as a primary endpoint. A 2015 study by Leyden et al. (Journal of Cosmetic Dermatology) showed peptide-containing formulations improved facial appearance, but that's a category result, not a GHK-Cu-specific finding. Anyone claiming GHK-Cu definitively treats melasma is getting ahead of the evidence.

What did they get wrong (or right)?

Courtney got the framing right. She didn't claim GHK-Cu cured her melasma, she said she's "pretty happy" with how things look after three months. That's honest. She also disclosed her makeup, which matters because melasma before-and-afters are notoriously manipulated by lighting and coverage choices.

What's missing is any acknowledgment that GHK-Cu is typically applied topically as a cosmetic ingredient, and its bioavailability and penetration depth through intact skin are legitimate open questions. Pickart's own research focused heavily on wound models where the skin barrier is compromised. Whether GHK-Cu reaches the dermis in meaningful concentrations through a serum or cream on healthy skin is not fully established. She's also using a product with a trademarked-sounding name, "George Casey," which raises questions about formulation concentration and delivery vehicle that the video doesn't address.

What should you actually know?

GHK-Cu is one of the more credible peptides in the cosmetic space. It has a longer research history than most influencer-hyped compounds, and the mechanism of action, binding copper ions and modulating gene expression related to skin repair, is biologically plausible. Pickart's decades of work on this molecule is peer-reviewed and reproducible in lab settings.

But three months of results from one person wearing makeup in a TikTok video is not evidence of efficacy. Melasma is a hormonally driven, UV-sensitive condition that fluctuates on its own. Without a control, a consistent photography setup, and a validated outcome measure like the MASI score, there's no way to know whether GHK-Cu did the work, the season changed, she started wearing better SPF, or the melasma naturally cycled down. If you're considering GHK-Cu for melasma, the honest answer is that a dermatologist-supervised approach combining proven agents like tranexamic acid or azelaic acid has far more clinical support behind it.